BioSpace News Archive

Business

Spotlight Therapeutics Appoints Visionary Global Pharma Drug Developer Antoine Yver, M.D., M.Sc. as First Independent Board Member

Dr. Yver Brings More Than 30 Years of Industry Experience Including 11 Different Biologics and Small Molecule New Drug Approvals.

July 12, 2022
·
3 min read
Business

Ceapro Bolsters Executive Management Team with Appointment of Sigrun Watson as Chief Revenue Officer

Ceapro Inc. announced the appointment of Sigrun Watson as its Chief Revenue Officer, responsible for corporate strategy development and execution across the Cosmeceutical and personal care brand business, as well as Ceapro’s expansion into the Nutraceutical and Pharmaceutical markets.

July 12, 2022
·
4 min read
Biotech Beach

OmniPathology Announces the Launch of its Oropharyngeal HPV PCR TestNew oropharyngeal Human Papillomavirus (HPV) PCR test helps screen for oropharyngeal cancer and detection of early premalignant lesions

OmniPathology, an independent, physician-owned and operated pathology lab, today announced the launch of a new oral test for human papillomavirus (HPV) that can cause cancer.

July 12, 2022
·
2 min read
BioCapital

Processa Pharmaceuticals to Present at the World Orphan Drug Congress USA, July 11-13, 2022

Processa Pharmaceuticals, Inc. announced that Dr. David Young, it’s Chief Executive Officer, will present “Thinking Regulatory First - Considerations for the Effective Development of Rare Disease Therapies” at the World Orphan Drug Congress USA 2022 Conference on Wednesday, July 13, 2022 at 3:25 pm EDT.

July 12, 2022
·
3 min read
Business

Gilead Sciences Appoints Deborah Telman as Executive Vice President, Corporate Affairs and General Counsel

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Deborah Telman will join the company as Executive Vice President, Corporate Affairs and General Counsel, and will become a member of the company’s senior leadership team, reporting to Chairman and Chief Executive Officer Daniel O’Day.

July 12, 2022
·
3 min read
Pharm Country

B. Braun Launches Introcan Safety® 2 IV Catheter with One-time Blood Control Designed to Make IV Access Safer for Clinicians

B. Braun Medical Inc. (B. Braun), a leader in infusion therapy, announced today the launch of its new Introcan Safety 2 IV Catheter with one-time blood control.

July 12, 2022
·
4 min read
BioMidwest

Societal CDMO Announces Signing of Amendment to License and Supply Agreement With Lannett for Marketing of Verapamil PM and Verelan SR Products

Societal CDMO, Inc. announced that it has signed an amendment to its license and supply agreement with Lannett Company for the marketing of Verapamil PM and Verelan SR products.

July 12, 2022
·
4 min read
Business

Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug

Akanda Corp. and Tetra Bio-Pharma today jointly announced that Akanda will supply Tetra with pharmaceutical grade cannabis flower in a microdose cap form, for use in a Storz & Bickel Mighty Medic Vaporizer for global commercialization of Tetra’s QIXLEEFTM and related products.

July 12, 2022
·
9 min read
Business

Akoya to Report Second Quarter 2022 Financial Results on August 8th, 2022

Akoya Biosciences, Inc., The Spatial Biology Company®, announced that it will release financial results for the second quarter of 2022 after the market close on Monday, August 8th, 2022.

July 12, 2022
·
1 min read
Business

Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022

Certara, Inc., a global leader in biosimulation, announced that it will release financial results for the second quarter of 2022 after the market close on Tuesday, August 9th, 2022.

July 12, 2022
·
1 min read